Potential Benefits of Iopofosine I 131 in Waldenström Macroglobulinemia

A new radiotherapeutic agent, iopofosine I 131, is showing promising potential for patients with Waldenström macroglobulinemia, according to Francisco Hernandez-Ilizaliturri, MD, of Roswell Park Comprehensive Cancer Center. The initial phase 2 CLOVER-1 trial demonstrated notable efficacy and safety signals for heavily pretreated patients with this condition, leading to the initiation of the CLOVER-WaM expansion cohort specifically for Waldenström macroglobulinemia.

Preliminary data from the expansion cohort indicated durable responses and a manageable safety profile for iopofosine I 131, with ongoing observations suggesting that responses may continue to improve months after treatment completion. This unique feature could give iopofosine I 131 an advantage over current therapies, Hernandez-Ilizaliturri noted.

One of the key features of iopofosine I 131 is its novel mechanism of action and finite treatment duration compared to continuous therapies like BTK inhibitors. Despite providing deep responses, iopofosine I 131 allows for treatment completion, which may be preferable for some patients.

Safety data from 44 patients with Waldenström macroglobulinemia receiving iopofosine I 131 showed primarily grade 1/2 hematologic toxicities, with reversible instances of grade 3 or higher anemia or neutropenia. Importantly, no vascular or renal adverse effects were reported with iopofosine I 131, setting it apart from other available agents for this condition.

Overall, the preliminary efficacy and safety findings suggest that iopofosine I 131 could be a favorable therapeutic option for patients with Waldenström macroglobulinemia. This new radiotherapeutic agent offers hope for improved outcomes in this patient population.

spot_img

More from this stream

Recomended

Mānuka: The hottest super-ingredient powering a skincare revolution

PRWire

  Get ready, Los Angeles! Launching soon, MN8 is shaking up skincare with a groundbreaking debut set to redefine natural...

PRWire Press release Distribution Service.

MFMC’s Triumphant Presence at Future Hospitality Summit (FHS) World 2024, Dubai

PRWire

The Maldives Fund Management Corporation (MFMC) participated in the prestigious Future Hospitality Summit (FHS) 2024, held in Dubai from September...

PRWire Press release Distribution Service.

MFMC’s Triumphant Presence at Future Hospitality Summit (FHS) World 2024, Dubai

PRWire

The Maldives Fund Management Corporation (MFMC) participated in the prestigious Future Hospitality Summit (FHS) 2024, held in Dubai from September...

PRWire Press release Distribution Service.

FreeAgent CRM Rebrands to Servis.ai to Transform Customer-Facing Operations with AI-Powered Insights

PRWire

FreeAgent CRM, a leader in customer operations management, today announced a major rebranding initiative. The company will now operate as...

PRWire Press release Distribution Service.

EVO Wealth Consulting Launches Wealth Technology Solution Guide with 22 Industry Leaders

PRWire

EVO Wealth Consulting Launches Wealth Technology Solution Guide with 22 Industry Leaders EVO Wealth Consulting (EVO), is proud to introduce...

PRWire Press release Distribution Service.

Celebrating WWII veteran, grandfather and all-around mensch Charles Wilson as he turns 100

PRWire

If someone asked, “What would you do for your 100th birthday?” the first answer probably wouldn’t be, “Head into work.”...

PRWire Press release Distribution Service.